Malaysia
Search
Sign In
Change Password
Points
Sign Out
The global community is celebrating World Stomach Day on October 2, now in its second year, and the date itself reminds us of the very first report of Helicobacter pylori in 1982.
Extended exposure to proton pump inhibitors (PPIs) may raise mortality risk in individuals with decompensated cirrhosis, according to a Singapore study.
Advancements in genomics has paved the way for better classifications of colorectal cancers (CRC) and the use of precision therapy.
The combination of TAS-118 and oxaliplatin led to significantly greater survival compared with the S-1 and cisplatin combination in patients with metastatic or recurrent HER2-negative gastric cancer, the phase III SOLAR* study showed.
Reducing the dose of regorafenib did little to affect the overall tolerability of the drug in patients with metastatic colorectal cancer (mCRC), according to the phase II REARRANGE* trial presented at ESMO GI 2019.
Treatment with the direct-acting antiviral (DAA) combination of glecaprevir and pibrentasvir led to encouraging sustained virological response (SVR) among individuals with hepatitis C virus (HCV) infection, results of two real-world studies presented at the International Liver Congress™ (ILC 2019) showed.
The trend in liver disease-related mortality in individuals with HIV has changed, with a reduction in the incidence of viral hepatitis-related deaths and an increase in non-alcoholic fatty liver disease (NAFLD)-related deaths, according to a study presented at the International Liver Congress™ (ILC 2019).
.jpg)
